InvestSMART

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)+

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Antisense Therapeutics Limited (ANP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 ATL1103 Deed of Settlement, Termination and Transfer 29 Apr 2016 9:57AM $0.032 $0.058 risen by 81.25%
$52 Appendix 4C - quarterly 22 Apr 2016 9:28AM $0.035 $0.058 risen by 65.71%
$52 COR-004/ATL1103 Project Update 9 Mar 2016 9:12AM $0.055 $0.058 risen by 5.45%
$52 Trading Halt Request 7 Mar 2016 12:04PM $0.055 $0.058 risen by 5.45%
$52 Trading Halt 7 Mar 2016 11:12AM $0.055 $0.058 risen by 5.45%
$52 Half Yearly Report and Accounts 23 Feb 2016 4:29PM $0.048 $0.058 risen by 20.83%
$52 Company Update 15 Feb 2016 9:46AM $0.044 $0.058 risen by 31.82%
$52 Appendix 4C - quarterly 28 Jan 2016 9:11AM $0.055 $0.058 risen by 5.45%
$52 Antisense Therapeutics to present at Biotech Showcase 2016 17 Dec 2015 9:53AM $0.067 $0.058 fallen by 13.43%
$52 ATL1102 Cancer Data Presentation 8 Dec 2015 9:09AM $0.070 $0.058 fallen by 17.14%
$52 Receipt of R&D Tax Incentive payment 1 Dec 2015 8:52AM $0.078 $0.058 fallen by 25.64%
$52 ANP Licensing Partner povides Update on Corporate Progress 19 Nov 2015 9:43AM $0.086 $0.058 fallen by 32.56%
$52 Response to ASX Price Query 17 Nov 2015 9:26AM $0.090 $0.058 fallen by 35.56%
$52 Final Director's Interest Notice 16 Nov 2015 9:26AM $0.072 $0.058 fallen by 19.44%
$52 Results of Meeting and Chairman's Address 12 Nov 2015 3:27PM $0.071 $0.058 fallen by 18.31%
$52 Initial Director's Interest Notice (GP) 10 Nov 2015 3:58PM $0.075 $0.058 fallen by 22.67%
$52 Appointment of Non-Executive Director 9 Nov 2015 9:19AM $0.077 $0.058 fallen by 24.68%
$52 ATL1103 Data Presentation at Scientific Conference 4 Nov 2015 9:25AM $0.085 $0.058 fallen by 31.76%
$52 Change of Director's Interest Notice (RM) 27 Oct 2015 8:48AM $0.081 $0.058 fallen by 28.40%
$52 Change of Director's Interest Notice (MD) 21 Oct 2015 3:03PM $0.080 $0.058 fallen by 27.50%
$52 ANP Licensing Partner Strongbridge Announces Pricing of IPO 19 Oct 2015 10:05AM $0.090 $0.058 fallen by 35.56%
$52 Appendix 4C - quarterly 16 Oct 2015 9:06AM $0.080 $0.058 fallen by 27.50%
$52 Initial Director's Interest Notice 15 Oct 2015 9:52AM $0.089 $0.058 fallen by 34.83%
$52 Appointment of Non-Executive Director 15 Oct 2015 9:08AM $0.089 $0.058 fallen by 34.83%
$52 Notice of Annual General Meeting and Annual Report 12 Oct 2015 5:00PM $0.087 $0.058 fallen by 33.33%

426 - 450 of 707 results

Page 18 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.